U.S. flag

An official website of the United States government

NM_145200.5(CABP4):c.370C>T (p.Arg124Cys) AND Cone-rod synaptic disorder, congenital nonprogressive

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Apr 27, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000002030.7

Allele description [Variation Report for NM_145200.5(CABP4):c.370C>T (p.Arg124Cys)]

NM_145200.5(CABP4):c.370C>T (p.Arg124Cys)

Gene:
CABP4:calcium binding protein 4 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q13.2
Genomic location:
Preferred name:
NM_145200.5(CABP4):c.370C>T (p.Arg124Cys)
HGVS:
  • NC_000011.10:g.67456191C>T
  • NG_021211.1:g.5845C>T
  • NM_001300895.3:c.55C>T
  • NM_001300896.3:c.55C>T
  • NM_001379183.1:c.55C>T
  • NM_145200.5:c.370C>TMANE SELECT
  • NP_001287824.1:p.Arg19Cys
  • NP_001287825.1:p.Arg19Cys
  • NP_001366112.1:p.Arg19Cys
  • NP_660201.1:p.Arg124Cys
  • NC_000011.9:g.67223662C>T
  • NM_145200.3:c.370C>T
  • P57796:p.Arg124Cys
Protein change:
R124C; ARG124CYS
Links:
UniProtKB: P57796#VAR_029375; OMIM: 608965.0002; dbSNP: rs121917828
NCBI 1000 Genomes Browser:
rs121917828
Molecular consequence:
  • NM_001300895.3:c.55C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001300896.3:c.55C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001379183.1:c.55C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_145200.5:c.370C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cone-rod synaptic disorder, congenital nonprogressive
Synonyms:
NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE; Congenital stationary night blindness, type 2B
Identifiers:
MONDO: MONDO:0012490; MedGen: C4041558; Orphanet: 215; OMIM: 610427

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000022188OMIM
no assertion criteria provided
Pathogenic
(Oct 1, 2006)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV001260991Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 13 December 2019)
Uncertain significance
(Apr 27, 2017)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness.

Zeitz C, Kloeckener-Gruissem B, Forster U, Kohl S, Magyar I, Wissinger B, Mátyás G, Borruat FX, Schorderet DF, Zrenner E, Munier FL, Berger W.

Am J Hum Genet. 2006 Oct;79(4):657-67. Epub 2006 Aug 23.

PubMed [citation]
PMID:
16960802
PMCID:
PMC1592568

Structural insights into activation of the retinal L-type Ca²⁺ channel (Cav1.4) by Ca²⁺-binding protein 4 (CaBP4).

Park S, Li C, Haeseleer F, Palczewski K, Ames JB.

J Biol Chem. 2014 Nov 7;289(45):31262-73. doi: 10.1074/jbc.M114.604439. Epub 2014 Sep 25.

PubMed [citation]
PMID:
25258313
PMCID:
PMC4223327
See all PubMed Citations (5)

Details of each submission

From OMIM, SCV000022188.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a 15-year-old boy of Swiss ancestry with congenital nonprogressive cone-rod synaptic disorder (CRSD; 610427), Zeitz et al. (2006) identified compound heterozygosity for a 2-bp deletion in the CABP4 gene (608965.0001) and a c.370C-T transition in exon 2, predicted to introduce a binding site for SRp55 (SRSF6; 601944) and influence splicing, or to result in an arg124-to-cys (R124C) substitution. His unaffected parents were each heterozygous for 1 of the mutations, which were not found in 216 or 228 control alleles, respectively. The patient exhibited CABP4 transcript levels 30 to 40% of those found in controls.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Illumina Laboratory Services, Illumina, SCV001260991.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024